Back to top

gene-editing: Archive

Sundeep Ganoria

Will AbbVie's Acquisition Spree Aid Pipeline Growth?

ABBV's $2.1 billion Capstan deal and 20+ recent acquisitions sharpen its pipeline edge across immunology and beyond.

SNYNegative Net Change LLYPositive Net Change ABBVNegative Net Change